Oxford PharmaGenesis™ opens new base in mainland Europe

Oxford PharmaGenesis™, the independent global HealthScience™ Communications Consultancy, formally opened its first Swiss office today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Quote startI am very excited to be leading this major new contribution to health science in SwitzerlandQuote end

Basel, Switzerland (PRWEB UK) 12 October 2012

Oxford PharmaGenesis™, the independent global HealthScience™ Communications Consultancy, has formally opened its office in Switzerland.

Under the leadership of Dr Paul Strijbos, an industry professional with 20 years of experience, Oxford PharmaGenesis™ AG offers the full range of services available from the 100-strong global team.

“I am very excited to be leading this major new contribution to health science in Switzerland”, said Paul. “From orphan drugs to value demonstration, from public policy to regulatory affairs, and from medical communications to publication planning, we offer a comprehensive service based on our long-term global reputation for delivery excellence. I am particularly pleased that Ruth Bentley, an editorial expert with over 25 years of experience, will guide all aspects of client delivery.”

The opening party was hosted by company founder, Dr Graham Shelton. “This marks a significant step in the growth of Oxford PharmaGenesis™, which now comprises four offices – in Oxford, London, Philadelphia and Basel”, said Graham. “We believe in developing supportive, long-term relationships with our clients, and this new base in mainland Europe equips us to provide an even higher level of quality service.”

For further information please contact Paul Strijbos
Tel: +41 (0)61 204 4561        
Tel: +44 (0)1865 390144
paul.strijbos (at) pharmagenesis (dot) com


Contact

  • Paul Strijbos
    Oxford PharmaGenesis
    +41 (0)61 204 4561
    Email

Attachments